Stryker Corporation logo
Stryker Corporation (SYK)
Compare

Stryker Corporation (SYK) Price History:-17.66%(TTM)

Compare

Over the latest trailing 12-month period, Stryker Corporation (SYK)'s price cagr is -17.66%. The comparable SPY value is +24.52%. Year-to-date price return is -10.80%. Price CAGR uses adjusted close price history and excludes dividends.

Current Price

$310.58

+$2.64 (+0.86%)

Previous Close: $307.94

Last Session

Open
$309.24
Day High
$311.50
Day Low
$305.80
Volume
1.72M
Avg Volume
2.49M

52-Week Position

24%

of the 52-week price range

From 52-week high
-23.29%
From 52-week low
+10.53%

52-Week Price Range

52-Week Low

$281.00

May 11, 2026

Current Price

$310.58

24% of range

52-Week High

$404.87

Jul 25, 2025

Low (+10.53% from current)(-23.29% from current) High

Price Returns by Period

1 Day

+0.86%

7 Days

+0.56%

30 Days

-0.84%

YTD

-10.80%

1 Year

-16.82%

vs 52W High

-23.29%

SYK Price Chart

End-of-day pricesAdvanced chart →
SYK$310.58 -16.79%(1Y)as of Jun 16, 2026

Long-Term Performance (CAGR)

Price CAGR (3Y)

+1.80%

Price CAGR (5Y)

+3.91%

Total Return CAGR (3Y)

+2.79%

Total Return CAGR (5Y)

+4.98%

CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.

Key Price Statistics

Current Price$310.58
Previous Close$307.94
Day Range$305.80 - $311.50
52-Week Range$281.00 - $404.87
Volume1.72M
Average Volume2.49M
Market Cap$119.06B
% from 52W High-23.29%
Data as of Wednesday, June 17, 2026

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI
53,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo